288 related articles for article (PubMed ID: 34065298)
1. A Potential Role for HUWE1 in Modulating Cisplatin Sensitivity.
Wenmaekers S; Viergever BJ; Kumar G; Kranenburg O; Black PC; Daugaard M; Meijer RP
Cells; 2021 May; 10(5):. PubMed ID: 34065298
[TBL] [Abstract][Full Text] [Related]
2. The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.
Gong X; Du D; Deng Y; Zhou Y; Sun L; Yuan S
Invest New Drugs; 2020 Apr; 38(2):515-524. PubMed ID: 32008177
[TBL] [Abstract][Full Text] [Related]
3. Tobramycin suppresses HUWE1 degradation to control MCL-1 stability during tumour development.
He J; Wu S; Li X; Tang L; Chen H; Qin L; Xie J; Lu T; Xu W
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1600-1610. PubMed ID: 32378766
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination by HUWE1 in tumorigenesis and beyond.
Kao SH; Wu HT; Wu KJ
J Biomed Sci; 2018 Sep; 25(1):67. PubMed ID: 30176860
[TBL] [Abstract][Full Text] [Related]
5. ATG101 Degradation by HUWE1-Mediated Ubiquitination Impairs Autophagy and Reduces Survival in Cancer Cells.
Lee J; Kim J; Shin J; Kang Y; Choi J; Cheong H
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502089
[TBL] [Abstract][Full Text] [Related]
6. CRL4B
Liu F; Cao L; Zhang T; Chang F; Xu Y; Li Q; Deng J; Li L; Shao G
Biochem Biophys Res Commun; 2018 Jun; 501(2):440-447. PubMed ID: 29738775
[TBL] [Abstract][Full Text] [Related]
7. Solenoid architecture of HUWE1 contributes to ligase activity and substrate recognition.
Hunkeler M; Jin CY; Ma MW; Monda JK; Overwijn D; Bennett EJ; Fischer ES
Mol Cell; 2021 Sep; 81(17):3468-3480.e7. PubMed ID: 34314700
[TBL] [Abstract][Full Text] [Related]
8. The giant E3 ligase HUWE1 is linked to tumorigenesis, spermatogenesis, intellectual disability, and inflammatory diseases.
Qi L; Xu X; Qi X
Front Cell Infect Microbiol; 2022; 12():905906. PubMed ID: 35937685
[TBL] [Abstract][Full Text] [Related]
9. Direct regulation of Chk1 protein stability by E3 ubiquitin ligase HUWE1.
Cassidy KB; Bang S; Kurokawa M; Gerber SA
FEBS J; 2020 May; 287(10):1985-1999. PubMed ID: 31713291
[TBL] [Abstract][Full Text] [Related]
10. The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression.
Yuan Y; Wang LH; Zhao XX; Wang J; Zhang MS; Ma QH; Wei S; Yan ZX; Cheng Y; Chen XQ; Zou HB; Ge J; Wang Y; Zhang X; Cui YH; Luo T; Bian XW
Cancer Commun (Lond); 2022 Sep; 42(9):868-886. PubMed ID: 35848447
[TBL] [Abstract][Full Text] [Related]
11. Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models.
Kunz V; Bommert KS; Kruk J; Schwinning D; Chatterjee M; Stühmer T; Bargou R; Bommert K
Sci Rep; 2020 Oct; 10(1):18419. PubMed ID: 33116152
[TBL] [Abstract][Full Text] [Related]
12. A novel SNP in HUWE1 promoter confers increased risk of NOA by affecting the RA/RARα pathway in Chinese individuals.
Shan X; Zhang X; Huang G; Lv J; Ye Z; Jiang C; Jiang X; Cheng J; Lin H; Jiang H; Yue H; Wang Z; Xu W
Andrology; 2024 Feb; 12(2):338-348. PubMed ID: 37290064
[TBL] [Abstract][Full Text] [Related]
13. HUWE1 interacts with PCNA to alleviate replication stress.
Choe KN; Nicolae CM; Constantin D; Imamura Kawasawa Y; Delgado-Diaz MR; De S; Freire R; Smits VA; Moldovan GL
EMBO Rep; 2016 Jun; 17(6):874-86. PubMed ID: 27146073
[TBL] [Abstract][Full Text] [Related]
14. A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53.
Kurokawa M; Kim J; Geradts J; Matsuura K; Liu L; Ran X; Xia W; Ribar TJ; Henao R; Dewhirst MW; Kim WJ; Lucas JE; Wang S; Spector NL; Kornbluth S
Sci Signal; 2013 May; 6(274):ra32. PubMed ID: 23652204
[TBL] [Abstract][Full Text] [Related]
15. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.
Atipairin A; Canyuk B; Ratanaphan A
Breast Cancer Res Treat; 2011 Feb; 126(1):203-9. PubMed ID: 20878461
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin ligase E3 HUWE1/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury.
Wu Y; Jiao H; Yue Y; He K; Jin Y; Zhang J; Zhang J; Wei Y; Luo H; Hao Z; Zhao X; Xia Q; Zhong Q; Zhang J
Cell Death Differ; 2022 Sep; 29(9):1705-1718. PubMed ID: 35260822
[TBL] [Abstract][Full Text] [Related]
18. The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.
Crawford LJ; Campbell DC; Morgan JJ; Lawson MA; Down JM; Chauhan D; McAvera RM; Morris TC; Hamilton C; Krishnan A; Rajalingam K; Chantry AD; Irvine AE
Oncogene; 2020 Jul; 39(27):5001-5014. PubMed ID: 32523091
[TBL] [Abstract][Full Text] [Related]
19. The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.
He Y; Zhou J; Wan Q
Invest New Drugs; 2021 Jun; 39(3):713-723. PubMed ID: 33405091
[TBL] [Abstract][Full Text] [Related]
20. The E3 ligase HUWE1 increases the sensitivity of CRC to oxaliplatin through TOMM20 degradation.
Lee C; Park SH; Yoon SK
Oncogene; 2024 Feb; 43(9):636-649. PubMed ID: 38184713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
